10-KFiling Date: Feb 11, 2026

Bristol Myers (BMY) 10-K (Feb 11, 2026)

bmy-20251231

View SEC Filing

ACC: 0000014272-26-000004

Key Financial Metrics2025 · 2025-12-31

Revenue$88.08B

Net Income$7.05B

Total Assets$90.04B

Stockholders' Equity$46.39B

Operating Cash Flow$14.16B

More filings from Bristol Myers (BMY)

Recent 10-K filings from other companies

Uranium Energy (UEC) 10-K · Sep 29, 2026Annual Report · ended 2026-07-31 · Rev $37.2M, NI -$137.3M
Copart (CPRT) 10-K · Sep 29, 2026Annual Report · ended 2026-07-31 · Rev $4.7B, NI $1.5B
Campbell's (CPB) 10-K · Sep 24, 2026Annual Report · ended 2026-08-02 · Rev $9.7B, NI $403.0M
Palo Alto (PANW) 10-K · Sep 10, 2026$21.1B CyberArk deal, GAAP EPS -75%
Intuit 10-K · Sep 9, 2026Revenue $21.4B, diluted EPS $16.46